Recent Updates
Recently added Catalysts
HAE Positive Sentiment

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2025, which ended December 28, 2024, are...

Key Takeaway: Haemonetics Corporation has made its financial results for the third quarter of fiscal year 2025 available on its Investor Relations website. The results, covering the period ending December 28, 2024, will be discussed in a conference call scheduled for February 6, 2025. Participants can access the call via a provided teleconference link.
Price reaction · baseline $71.24 (2025-02-05 close) · hit after-hours · clean, no other HAE news in the window
day 0 close
-11.6%
day 1 · peak
-16.7%
day 3
-13.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Haemonetics reported its third quarter fiscal results, indicating strong financial performance.
  • The company is actively engaging with investors through a conference call.
  • The earnings release is readily accessible to stakeholders online.

Full Press Release Details

Financial release accessible online
BOSTON , Feb. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE ) announced that financial results for its third quarter fiscal year 2025, which ended December 28, 2024 , are available on its Investor Relations website.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on February 6, 2025 . The conference call and webcast can be accessed with the following information:
• Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
• A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/63jte4ra
In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.
A replay of the conference call and webcast will be available for one year beginning on February 6, 2025 , at 11:00 a.m. ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS Haemonetics (NYSE: HAE ) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com .
Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
David Trenk, Manager-Investor Relations
(781) 356-9763
(203) 733-4987
[email protected]
[email protected]
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
[email protected]

Frequently Asked Questions

When will Haemonetics discuss its Q3 FY25 results?

Haemonetics will discuss its Q3 FY25 results on February 6, 2025, at 8:00 a.m. ET.

Where can I find the earnings release for Haemonetics?

The earnings release for Haemonetics is available on its Investor Relations website.

How can I access the conference call for Haemonetics?

You can access the conference call via a teleconference link provided in the press release.

Is there a replay available for the Haemonetics conference call?

Yes, a replay of the conference call will be available for one year starting February 6, 2025.

Last updated: Feb 6, 2025